How to Start a Pharmaceutical Import Business in Nigeria: NAFDAC, PCN & CAC Guide

With a population above 220 million, Nigeria is West Africa’s largest pharmaceutical market and one of the largest in Africa overall. The country’s roughly 200 registered pharmaceutical companies produce only a fraction of what the population needs, which is why more than NAFDAC Drug registration certificate: 5-year validity under current NAFDAC guidance — active pharmaceutical ingredients as much as finished dosage forms. India and China are consistently the two largest source countries, and Indian pharmaceutical exports to Nigeria alone were valued at over US$300 million in the most recent full trade year.

That gap is real demand, not a loophole — which is exactly why the regulatory system around it is strict rather than casual. Industry guides consistently rank NAFDAC among the more demanding regulators on the continent: it typically requires inspection of a foreign manufacturer’s site (or reliance on an existing WHO-prequalification or stringent regulatory authority approval) before a first imported product is registered, on top of the company- and premises-level licensing every pharmaceutical business needs.

“Starting a pharma import business” is not a single application — it’s four separate workstreams, run by three different bodies, on four different clocks. Confuse them and you end up with a licensed premises and nothing registered to sell, or a registered product with no legal entity or licensed pharmacist to move it. Here’s how they actually fit together:

For a first-time Nigerian entrepreneur sourcing from an Indian manufacturer, the workload splits cleanly between what happens on the ground in Nigeria and what your supplier provides from the plant. Knowing this split before you sign anything prevents the single most common cause of delay — a dossier stalled waiting on a document only one side can produce.

None of the individual steps below is obscure — Nigeria’s registration pathway is well documented. What actually determines your launch date is sequencing — getting company, premises and dossier work moving in parallel instead of one after another.

Nigeria’s pharmaceutical demand is concentrated: antimalarials, antibiotics, and medicines for hypertension and diabetes make up a large share of what actually moves, alongside a broad over-the-counter and generics segment that dominates the market by volume. Matching your product list to genuine, high-turnover demand — rather than registering a wide, ambitious catalogue on day one — determines whether your first year is spent selling or spent answering NAFDAC deficiency letters.

The supplier decision matters just as much as the product decision. A manufacturer that already holds WHO-GMP certification, has exported to regulated or semi-regulated markets before, and can readily produce a current Certificate of Pharmaceutical Product and site master file is a fundamentally different proposition to one that can’t — the difference shows up directly in whether NAFDAC can rely on existing approvals or has to schedule a fresh facility inspection.

• Start narrow. Register the two or three SKUs with the clearest demand first — each additional product multiplies fees and query-response load before any of them are earning.
• Ask for the paperwork before you ask for pricing. A supplier who can’t readily produce a WHO-GMP certificate, CPP and stability data will surface that gap as a NAFDAC query, not before.
• Prior African or NAFDAC registration experience is a genuine asset in a supplier — it usually means their documentation is already in the format NAFDAC expects.
• Verify, don’t just trust. Independently confirm a supplier’s WHO-GMP and regulatory credentials rather than relying on their own claims — counterfeit and substandard product remains a well-documented risk in the Nigerian market.

Before your first legal shipment can clear Nigerian customs, every item below needs to be in place. Use it as a working checklist against your own launch plan.

Official fees and typical market costs both vary — by ownership structure, product risk category, and who you work with — and change periodically. The honest guidance every credible source agrees on: confirm current figures directly with CAC, PCN and NAFDAC before you commit a budget. What you can plan around is the structure of the cost lines you’ll actually encounter:

Build 12–24 months into your launch plan from incorporation to a first legally cleared shipment. The single biggest variable is not any one regulator — it’s how much of the work you run in parallel rather than in sequence.

• Registering a business name instead of incorporating a company. A business name generally cannot hold the PCN and NAFDAC licenses a wholesale/import operation needs — this gets corrected eventually, but it costs months.
• Treating the superintendent pharmacist as a formality. PCN ties the license to that named individual. Losing them without formally notifying PCN suspends your ability to legally operate.
• Signing a lease before checking PCN’s siting rules. Distance-from-other-premises and storage-layout requirements can rule out a site you’ve already committed to.
• Filing for NAFDAC product registration before the trademark. This stalls the dossier at exactly the point it should be moving fastest.
• Importing commercial stock before registration is complete. Outside the specific drug-sample import permit used strictly for the registration process, commercial shipments without a registered product and valid documentation are held — or seized — at port.
• Choosing a supplier on price alone. A manufacturer who can’t readily produce a WHO-format CPP, current GMP certificate and stability data shows that gap as a NAFDAC query letter, not before you’ve committed.
• Registering a wide catalogue in one pass. Every additional SKU multiplies fees and query load before any of them are generating revenue — lead with the two or three products that fill a genuine gap.

Regulatory requirements, fees and timelines described here are indicative and change over time. Always verify the current position with the Corporate Affairs Commission, the Pharmacists Council of Nigeria, NAFDAC, and your own legal/regulatory advisors before acting. Nothing on this page constitutes legal, regulatory or financial advice.